Comparative Effectiveness of Intubating Devices in the Morbidly Obese

NCT ID: NCT01114945

Last Updated: 2016-04-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

121 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-05-31

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective, randomized study will compare the effectiveness of 4 different airway intubating devices which are most commonly used.

The four different devices are as follows: McGrath video laryngoscope, GlideScope video laryngoscope, Video-Mac video laryngoscope, and Macintosh size 4 direct laryngoscope.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypothesis: the use of a video laryngoscope will improve the glottic view compared to direct laryngoscopy, and secondarily, use of the video laryngoscope will reduce the time required to achieve successful tracheal intubation in patients undergoing bariatric surgery. (Weight loss surgery). The three types of video laryngoscopy devices include; the Verethon GlideScope, LMA McGrath and Karl-Storz Video-Mac.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Video-Mac

Video-Mac device used during intubation procedure

Group Type EXPERIMENTAL

Video-Mac

Intervention Type DEVICE

Intubation with the Video-Mac device

GlideScope

GlideScope device used during intubation procedure

Group Type EXPERIMENTAL

GlideScope

Intervention Type DEVICE

Intubation with the GlideScope device

McGrath

McGrath device used during intubation procedure

Group Type EXPERIMENTAL

McGrath

Intervention Type DEVICE

Intubation with the McGrath device

Direct Macintosh Laryngoscopy

Direct Macintosh Laryngoscopy (DL) used during intubation procedure

Group Type ACTIVE_COMPARATOR

Direct Macintosh Laryngoscopy

Intervention Type DEVICE

Intubation with Direct Macintosh Laryngoscope

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

McGrath

Intubation with the McGrath device

Intervention Type DEVICE

GlideScope

Intubation with the GlideScope device

Intervention Type DEVICE

Direct Macintosh Laryngoscopy

Intubation with Direct Macintosh Laryngoscope

Intervention Type DEVICE

Video-Mac

Intubation with the Video-Mac device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a documented body mass index (BMI) of \>35.
* Patients scheduled to undergo inpatient surgery procedures under general anesthesia.
* Willingness and ability to sign an informed consent document
* 18 - 80 years of age
* American Society of Anesthesiologists (ASA) Class II- III adults of either sex.

Exclusion Criteria

* Patients who are deemed to be such a significant of an airway risk that they necessitate awake fiberoptic intubation
* Patients with a history facial abnormalities, oral-pharyngeal cancer or reconstructive surgery
* Emergency surgeries
* Pregnancy
* The inability to tolerate 0.2mg of glycopyrrolate based on tachycardia.
* Any other conditions or use of any medication which may interfere with the conduct of the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cedars-Sinai Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Roya Yumul, M.D.,PhD.

Residency program director, Department of anesthesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Roya Yumul, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Cedars-Sinai Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cedars Sinai Medical Center

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00019199

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparison of Two Different Video Laryngoscopes
NCT06649526 ACTIVE_NOT_RECRUITING
Laryngeal Mask in Morbid Obesity
NCT04243564 WITHDRAWN NA